SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Gold, as represented by GLD, is trending significantly due to its relentless ascent to new all-time highs, sparking widespread debate. The community is split between those viewing it as a critical safe-haven play against currency debasement, persistent inflation, and global geopolitical tensions, and skeptics labeling it as an overheated "bubble" poised for a sharp correction. This surge, often mirroring a broader metals rally, is seen by many as a powerful indicator of underlying systemic concerns and a potential shift in trust from traditional fiat currencies towards hard assets.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is seeing a historic surge to new all-time highs, driven by significant global supply tightening, notably China's impending silver export restrictions, and accelerating industrial demand from AI data centers, EVs, and solar sectors. The community is actively discussing a potential parabolic "silver squeeze" and a major re-rating of its value, despite some warnings of an extremely overbought market and an anticipated near-term pullback.

Starfighters Space Inc

Starfighters Space Inc. ($FJET) is experiencing extreme volatility following its recent public listing, leading to intense debate across the community. While many anticipate a significant short squeeze opportunity due to its low float and extremely high short borrow fees, others are wary, pointing to the company's limited revenue and expressing concerns about a classic 'pump and dump' pattern.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending intensely due to anticipation surrounding its upcoming FDA Type B meeting for Sonelokimab in Hidradenitis Suppurativa and growing speculation of a potential acquisition, particularly by Merck. The community is actively discussing recent executive share conversions as a strategic move to prepare for a significant corporate event, fueled by strong conviction in SLK's "Best in Class" efficacy and large market potential.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending amidst ongoing arbitration cases with major energy players and recent analyst price target reductions, which continue to weigh on investor sentiment. Despite the operational strength reflected in new long-term contracts and ambitious expansion plans, the community remains sharply divided between those accumulating shares at perceived low valuations and those frustrated by persistent downside pressures and insider selling.

TOSHI

TOSHI is trending with its passionate 'blue cat' community actively accumulating, driven by anticipation of significant developments on the Base blockchain and potential major exchange listings. Investors are optimistic about its long-term potential as the 'Face of Base,' with many viewing current prices as a prime opportunity to build positions for substantial future growth.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is capturing significant attention ahead of its CES 2026 showcase, where it aims to highlight commercial quantum computing solutions and real-world applications. The stock is generating intense debate, with bulls pointing to its unique quantum annealing capabilities and increasing institutional ownership as signs of long-term potential, while bears voice strong concerns about its high valuation, minimal revenue, and executive stock sales, labeling it a manipulated pump-and-dump.

ProShares Trust - ProShares Ultra Bitcoin ETF

ProShares Ultra Bitcoin ETF

ProShares Ultra Bitcoin ETF ($BITU) recently saw a notable price drop, sparking immediate concern and confusion among investors. The community quickly identified this as a significant dividend or distribution payment, shifting conversations to its impact and the broader outlook for this leveraged Bitcoin ETF amid ongoing cryptocurrency market trends.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is seeing a surge in conversation following significant insider buying, notably from Apple CEO Tim Cook, which investors are interpreting as a strong vote of confidence. This has fueled widespread speculation of a potential short squeeze and a "Santa rally," with the community actively debating if this marks a key turning point for the stock after a period of depressed sentiment.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to significant new orders for its advanced transceivers, including a landmark 800G deal with a major hyperscale customer for AI-driven data centers, validating its critical role in the AI infrastructure buildout. This has fueled robust community discussion, strong price momentum, and recent analyst upgrades, with many anticipating continued growth and potential for a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acadian Asset Management LLC Boosts Position in Anika Therapeutics Inc. $ANIK

Acadian Asset Management LLC lifted its position in shares of Anika Therapeutics Inc. (NASDAQ:ANIK - Free Report) by 6.7% in the second quarter, according to its most recent filing with the...

Anika Therapeutics (NASDAQ:ANIK) Upgraded at Wall Street Zen

Wall Street Zen upgraded Anika Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Barrington Research Forecasts Strong Price Appreciation for Anika Therapeutics (NASDAQ:ANIK) Stock

Barrington Research increased their price target on shares of Anika Therapeutics from $15.00 to $16.00 and gave the company an "outperform" rating in a research note on Thursday...

Anika Therapeutics (NASDAQ:ANIK) Releases Quarterly Earnings Results, Misses Estimates By $0.19 EPS

Anika Therapeutics (NASDAQ:ANIK - Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, missing the...

Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates

Anika (ANIK) delivered earnings and revenue surprises of +100.00% and +0.06%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains?

Arcturus Therapeutics (ARCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?

The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Anika (ANIK) Upgraded to Buy: Here's What You Should Know

Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of 0.00% and +4.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates

uniQure (QURE) delivered earnings and revenue surprises of +22.47% and -26.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

ANIK
Anika Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANIK News

ANIKAnika Therapeutics Inc.